SCHEMBL6589296

SCHEMBL6589296

CC1(O)c2ccccc2C(=O)N1c1ccncc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.66
ALDH1A1 P00352 4/20 0.48
TSHR P16473 2/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 2/20 0.42
CYP2C9 P11712 2/20 0.42
MEN1 O00255 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
KMT2A Q03164 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
PGR P06401 4/20 0.41
KDM4E B2RXH2 2/20 0.39
KCNQ2 O43526 1/20 0.39
CYP3A4 P08684 1/20 0.39
ALOX15 P16050 1/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL6588742 0.91 RXFP1 (0.60) RXFP1ALDH1A1TSHRTP53CYP1A2
Fumaric Acid SCHEMBL6588746 0.91 RXFP1 (0.60) RXFP1ALDH1A1TSHRTP53CYP1A2
SCHEMBL6586651 0.81 RXFP1 (0.61) RXFP1ALDH1A1TSHRTP53CYP1A2
SCHEMBL6587023 0.79 RXFP1 (0.59) RXFP1ALDH1A1TSHRTP53CYP1A2
SCHEMBL6589132 0.77 RXFP1 (0.53) RXFP1ALDH1A1TSHRTP53CYP1A2
Maleic Acid SCHEMBL6589328 0.74 RXFP1 (0.56) RXFP1ALDH1A1TSHRTP53CYP1A2
Fumaric Acid SCHEMBL6589338 0.74 RXFP1 (0.56) RXFP1ALDH1A1TSHRTP53CYP1A2
SCHEMBL29155436 0.74 RXFP1 (0.55) RXFP1ALDH1A1TSHRTP53MEN1
SCHEMBL7688577 0.73 PARP1 (0.46) ALDH1A1CYP2C19NPSR1PGRKDM4E
SCHEMBL28232362 0.72 RXFP1 (0.54) RXFP1ALDH1A1TSHRTP53MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0703232-B1 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors AVENTIS PHARMA INC (US) 2004-06-30 EP claimed
EP-0703232-B1 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors AVENTIS PHARMA INC (US) 2004-06-30 EP disclosed
US-5874458-A PSYCHOLOGICAL DISORDERS HOECHST MARION ROUSSEL INC. (US) 1999-02-23 US disclosed
US-5874583-A TREATING DEPRESSION, OBSESSIVE COMPULSIVE DISORDER, STUTTERING, TRICHOTILLOMANIA HOECHST MARION ROUSSEL INC. (US) 1999-02-23 US disclosed
US-5869685-A SEROTONIN REUPTAKE INHIBITORS HOECHST MARION ROUSSEL INC. (US) 1999-02-09 US disclosed
US-5869502-A TREATING DEPRESSION, OBSESSIVE COMPULSIVE DISORDER, STUTTERING, TRICHOTILLOMANIA HOECHST MARION ROUSSEL INC. (US) 1999-02-09 US disclosed
US-5567718-A PSYCHOLOGICAL DISORDERS HOECHST MARION ROUSSEL INC. (US) 1996-10-22 US disclosed
EP-0703232-A2 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1996-03-27 EP disclosed